Following its $20 billion asset swap with GlaxoSmithKline last year, Novartis is to split its pharmaceutical division in two, creating two business units, with the former single business unit's ...

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

Truist highlights Novartis' strong balance sheet, which enables further bolt-on deals and share buybacks. Recent transactions primarily involve deals in the sub-$1 billion range, along with a few ...

Swiss pharmaceuticals group Novartis has said it will charge $475,000 (CHF458,000) a patient for its new cancer therapy, putting it among the most expensive drugs of all time. David Crow in New ...

Oct 28 (Reuters) - Swiss pharmaceutical giant Novartis (NOVN.S), opens new tab will pay Monte Rosa Therapeutics (GLUE.O), opens new tab $150 million upfront payment for a global license to develop ...

For years we have heard about "red states" and "blue states," so this must have been a thing since America established a two-party system...right? Simply put, no. The designation of colors for ...

Pharmaceutical giant Novartis is shutting down a San Diego facility as part of a broader restructuring of the company’s drug development segment. In the first phase of layoffs, the Basel ...

FRANKFURT, Oct 29 (Reuters) - Novartis (NOVN.S), opens new tab raised its 2024 earnings guidance for the third time on Tuesday, buoyed by wider use of its prescription drugs, but its shares fell ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. The deal, which features $1.1 billion in milestones, covers the global rights to a small ...

PETALING JAYA: Pharmaceutical firm Novartis Malaysia has set up a hybrid office in Plaza Imazium, Damansara Uptown, as part of its strategic growth strategy and commitment to future-proof its ...